Pfizer Slow-Plays Results Of COVID Vax Trial In Pregnant Women

  • When covid-19 vaccines were granted emergency authorization in Dec 2020, there was consternation over whether pregnant women should be vaccinated.
  • In the absence of any human data, Pfizer announced it would begin recruiting volunteers for a clinical trial to examine the safety and efficacy of its mRNA vaccine in pregnant women and their newborns.
  • The trial, which began in February 2021, originally intended to enroll 4,000 women, but enrollment stopped in late 2021 with just 349 participants.
Continue to Article

Popular Now on Off The Press